Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Pediatric Pulmonology|November 4, 2005
Peroxisome proliferator-activated receptors: potential therapeutic targets in lung disease?Gerene M Denning, Lynn L Stoll
Arteriosclerosis, Thrombosis, and Vascular Biology|October 9, 2004
Potential role of endotoxin as a proinflammatory mediator of atherosclerosisLynn L Stoll, Gerene M Denning, Neal L Weintraub
Current Pharmaceutical Design|November 15, 2006
Endotoxin, TLR4 signaling and vascular inflammation: potential therapeutic targets in cardiovascular diseaseLynn L Stoll, Gerene M Denning, Neal L Weintraub
Drugs of Today (Barcelona, Spain : 1998)|January 13, 2005
Antioxidant effects of statinsLynn L Stoll, Michael L McCormick, Gerene M Denning, et al.
Timely Topics in Medicine. Cardiovascular Diseases|April 13, 2005
Antioxidant effects of statinsLynn L Stoll, Michael L McCormick, Gerene M Denning, et al.
Current Opinion in Pharmacology|January 12, 2010
Crosstalk between perivascular adipose tissue and blood vesselsSrinivas Rajsheker, David Manka, Andra L Blomkalns, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 24, 2007
Exercise enhances myocardial ischemic tolerance via an opioid receptor-dependent mechanismEric W Dickson, Christopher P Hogrefe, Paula S Ludwig, et al.
Peptides|December 18, 2007
Proenkephalin expression and enkephalin release are widely observed in non-neuronal tissuesGerene M Denning, Laynez W Ackermann, Thomas J Barna, et al.
Journal of Inflammation (London, England)|March 1, 2011
Low level bacterial endotoxin activates two distinct signaling pathways in human peripheral blood mononuclear cellsAndra L Blomkalns, Lynn L Stoll, Wassim Shaheen, et al.
Pageof 2